Close Menu

NEW YORK (GenomeWeb) – Cepheid's Xpert Xpress Flu and Xpert Xpress Flu/RSV tests have received clearance from the US Food and Drug Administration, the firm announced today.

The tests are the first in the firm's planned line of Xpress branded tests — faster versions of the firm's Xpert test cartridges enabling test times of 30 minutes or less.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.